Wuxi Junuo To Present Latest Clinical Study Data Of Benoda At 2022 Asco Meeting

Wuxi Junuo, An Independent Innovative Biotechnology Company, Announced That In 2022 The American Society Of Clinical Oncology (Asco) Annual Meeting Presents The Latest Clinical Research Data Of Benoda In Poster Presentations And Online Presentations.Benoda (Ruiji Orenza Injection) Is A Cd19-Targeting Drug Independently Developed By Wuxi Ju Nuo On The Basis Of The Car-T Cell Technology Platform Of Ju Nuo Medical (A Bristol-Myers Squibb Company) Of Autologous Car-T Cell Immunotherapy Products. As Wuxi Junuo'S First Product, Benoda Was Approved By The China National Medical Products Administration In September 2021 For The Treatment Of Relapsed Or Refractory Large B Cells In Adult Patients After Second-Line Or Above Systemic Therapy Lymphoma (R/R Lbcl), Became The First Car-T Product Approved As A Class 1 Biological Product In China. Benoda Is Currently The Only Car- T Cell Immunotherapy Product In China That Has Received Three Awards At The Same Time, Including The "Major New Drug Creation" Project, The Priority Review Qualification For New Drug Marketing Applications, And The Breakthrough Therapy Drug Designation.Wuxi Junuo Is An Independent, Innovative Biotechnology Company Focused On The Development, Production And Commercialization Of Cellular Immunotherapy Products.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!